Multicentre Paediatric Disease Registry in Essential Thrombocythaemia
Multicentre Paediatric Disease Registry in Essential Thrombocythaemia
The aim of this study is to evaluate the progression of ET in children (aged 6-17years inclusive) over a period of 5 years maximum. The study will also assess how children are diagnosed, treatment options for those children with symptoms and events related to their ET and the outcomes of those treatments.
Inclusion Criteria:
- 6 years or over and less than 18 years patient has ET according to the WHO criteria as guidance
Exclusion Criteria:
Genova, Italy